Bulut, I.; Lee, A.; Cevatemre, B.; Ruzic, D.; Belle, R.; Kawamura, A.; Gul, S.; Nikolic, K.; Ganesan, A.; Acilan, C.
Dual LSD1 and HDAC6 Inhibition Induces Doxorubicin Sensitivity in Acute Myeloid Leukemia Cells. Cancers 2022, 14, 6014.
https://doi.org/10.3390/cancers14236014
AMA Style
Bulut I, Lee A, Cevatemre B, Ruzic D, Belle R, Kawamura A, Gul S, Nikolic K, Ganesan A, Acilan C.
Dual LSD1 and HDAC6 Inhibition Induces Doxorubicin Sensitivity in Acute Myeloid Leukemia Cells. Cancers. 2022; 14(23):6014.
https://doi.org/10.3390/cancers14236014
Chicago/Turabian Style
Bulut, Ipek, Adam Lee, Buse Cevatemre, Dusan Ruzic, Roman Belle, Akane Kawamura, Sheraz Gul, Katarina Nikolic, A. Ganesan, and Ceyda Acilan.
2022. "Dual LSD1 and HDAC6 Inhibition Induces Doxorubicin Sensitivity in Acute Myeloid Leukemia Cells" Cancers 14, no. 23: 6014.
https://doi.org/10.3390/cancers14236014
APA Style
Bulut, I., Lee, A., Cevatemre, B., Ruzic, D., Belle, R., Kawamura, A., Gul, S., Nikolic, K., Ganesan, A., & Acilan, C.
(2022). Dual LSD1 and HDAC6 Inhibition Induces Doxorubicin Sensitivity in Acute Myeloid Leukemia Cells. Cancers, 14(23), 6014.
https://doi.org/10.3390/cancers14236014